Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist

 
• By Kevin Grogan
EFPIA leadership
David Loew, Nathalie Moll, Lars Fruergaard Jørgensen (Novo Nordisk CEO and EFPIA president) and Stefan Oelrich (head of pharma at Bayer and EFPIA first vice president) • Source: EFPIA

More from Drug Pricing

More from Scrip